Indeed, the prevalence of BRAF-mutated CRC was relatively low (6.4%) in the Japanese Nationwide Cancer Genome Screening Project (SCRUM-Japan), compared to those of large-scale studies mainly conducted in Western countries (8–12%) [3,37]. The gene discussed is BRAF; the disease is cancer.